spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

CBIs Global Risk Based Monitoring Event

CBI IDMP


A note from their co-chairs:
We are pleased to invite you to join us at CBI’s Global Risk-Based Monitoring. We’ve created an agenda that blends roundtable discussions along with key presentations to maximize interactive discussions.

Whether you are developing your first RBM strategy or fully immersed in global RBM implementation, we’ve included topics that align with all stages of RBM implementation:

• Create efficiencies for your central monitoring team
• Benchmark against global industry leaders from around the world
• Create a library for RACTS and risk classifications
• Evaluate RBM capabilities of your CROs/AROs
• Determine the right trial to implement RBM
• Adapt your RBM strategy to ICH E6 (R2)

We’ve selected key industry and academic research experts to share their experiences and perspectives on RBM and its implementation. We are eager to have you join us in London this September to share your own RBM experiences and expand this global professional network with us in an interactive setting.

We look forward to seeing you in London!

Lisa Berdan
Director, Global Mega Trials
Duke Clinical Research Institute

Carol Knott
Head of Monitoring and Nurse Training
University of Oxford

Take advantage of their $500 discount with discount code LON500 upon registering.
For more information on registering and/or team rates, please contact:

Matt Hannon
Professional Development Advisor
CBI, a division of UBM Americas
matt.hannon@cbinet.com | 339-298-2157
phone +1 (339) 298-2142
email sonia.lima@cbinet.com
 
Print this page
Send to a friend
   
spacer
News and Press Releases

BioIVT Publishes New Research On the Mechanisms Underlying the C-DILI Assay

BioIVT, a leading provider of research models and services for drug development, today announced its research into the mechanisms involved in cholestatic drug-induced liver injury (DILI) has been published in Applied In Vitro Toxicology.1
More info >>


White Papers

Translating Cancer Genomics Into A Personalised Approach For Cancer Patients

PRA Health Sciences (PRA)

Over the past few decades, the approach to prevention, diagnosis and treatment of cancer has radically shifted from organ-based to morphology-based and most recently, to genetics-based. Personalized or precision medicine (tailoring a treatment for a patient’s particular disease at a precise time point) is being performed every day at different levels in the clinical setting.
More info >>

Industry Events

Clinical Trial Supply Southeast 2018

2-3 October 2018, Cary, North Carolina

Clinical Trial Supply Southeast will return to Cary, North Carolina for fall 2018. Part of our global series of events, this show will attract the leading biotech and pharma companies from the Southeast region, the event will focus on how companies can adapt their supply chains to fit into the highly regulated world.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement